Scientific work

Uzm. Dr. Hatice Ayyıldız Sevim

17 publications. The source of the information is stated next to each publication.

Back to profile

  1. Association Between Treatment-Emergent Pancreatic Volume Loss and Survival Outcomes in Patients with Metastatic Colorectal Cancer Receiving Bevacizumab

    Medicina, 2026

    DOI 10.3390/medicina62081459 PMID 42654356 Open-access full textSource: OpenAlex

  2. Quality of Life and Psychological Factors in Patients with Metastatic Prostate Cancer Receiving Androgen Receptor–Targeted Therapies: A Prospective Cross-Sectional Real-World Study

    Medicina, 2026

    DOI 10.3390/medicina62061175 PMID 42356187 Open-access full textSource: OpenAlex

  3. Independent factors associated with advanced testicular germ cell tumors: the roles of smoking, lymphovascular invasion, and tumor size

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-15598-y PMID 41555284 Open-access full textSource: OpenAlex

  4. Emergency Surgery Independently Predicts Postoperative Recurrence in Patients with Pathologic T3N0M0 Colon Cancer: A Retrospective Single-Center Cohort Study

    Current Oncology, 2026

    DOI 10.3390/curroncol33090526 PMID 42782872 Open-access full textSource: OpenAlex

  5. Quality of Life and Patient-Reported Outcomes During First-Line Chemotherapy in Older Patients with De Novo Metastatic Gastrointestinal Cancers: A Prospective Longitudinal Study

    Healthcare, 2026

    DOI 10.3390/healthcare14203458 PMID 42940505 Open-access full textSource: ORCID

  6. Prognostic and Treatment-Context Associations of EASIX and IPI in Extensive-Stage Small-Cell Lung Cancer Patients Receiving First-Line Therapy

    Cancers, 2026

    DOI 10.3390/cancers18172888 PMID 42738408 Open-access full textSource: ORCID

  7. Association of Primary Tumor Resection with Survival in De Novo Stage IV Colorectal Cancer: A Retrospective Cohort Study with Propensity Score Matching

    Current Oncology, 2026

    DOI 10.3390/curroncol33080467 PMID 42645372 Open-access full textSource: ORCID

  8. C-Reactive Protein–Albumin–Lymphocyte Index and the Modified Glasgow Prognostic Score as Predictors of Early Mortality After Palliative Percutaneous Transhepatic Biliary Drainage in Malignant Biliary Obstruction

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15124608 PMID 42355776 Open-access full textSource: ORCID

  9. Concomitant Metformin Use During Nivolumab Therapy for Advanced Non-Small Cell Lung Cancer: A Real-World Analysis of Survival Outcomes

    Acta haematologica oncologica Turcica., 2026

    DOI 10.4274/ahot.galenos.2026.2026-7-6 Open-access full textSource: OpenAlex

  10. Mean platelet volume-to-albumin ratio as a predictor of pathological complete response in HER2-positive breast cancer undergoing neoadjuvant chemotherapy

    Discover Oncology, 2026

    DOI 10.1007/s12672-026-04938-w PMID 41979751 Open-access full textSource: OpenAlex

  11. Comparison of Anthracycline-Containing and Anthracycline-Free Neoadjuvant Regimens in HER2-Positive Breast Cancer

    Research Square, 2026

    DOI 10.21203/rs.3.rs-8673435/v1 Open-access full textSource: OpenAlex

  12. Comparison of anthracycline-containing and anthracycline-free neoadjuvant regimens in HER2-positive breast cancer.

    Journal of Clinical Oncology, 2026

    DOI 10.1200/jco.2026.44.16_suppl.e13021 Source: OpenAlex

  13. Do Inflammatory and Nutritional Markers Predict Prognosis in Metastatic Non-Small Cell Lung Cancer Patients Receiving Nivolumab

    Journal of inflammation research, 2025

    DOI 10.2147/jir.s541842 PMID 41209385 4 citations (Europe PMC) Open-access full textSource: Europe PMC

  14. Effect of treating glioblastoma with a cytokine inhibitor, ibudilast, in combination with temozolomide on survival in a patient-derived xenograft model.

    Journal of Clinical Oncology, 2017

    DOI 10.1200/jco.2017.35.15_suppl.2062 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  15. MIF-CD74 GUIDED THERAPEUTIC STRATEGY FOR THE UPFRONT TREATMENT OF GBM PATIENTS WITH AN UNMETHYLATED MGMT PROMOTER

    Neuro-Oncology, 2014

    DOI 10.1093/neuonc/nou206.15 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  16. Abstract 2844: MIF/CD74 guided therapeutic strategy for relapsed glioblastoma patients

    Cancer Research, 2014

    DOI 10.1158/1538-7445.am2014-2844 Source: OpenAlex

  17. Abstract 5094: Protein biomarker discovery in glioblastoma using Seldi-Tof-MS

    Cancer Research, 2011

    DOI 10.1158/1538-7445.am2011-5094 Source: OpenAlex